Remove 2026 Remove Government Remove Patients Remove Vaccination
article thumbnail

Landmark Drug Pricing Bill Set to Become Law; HP&M Releases Summary Slide Deck

FDA Law Blog

The number will begin in 2026 with 10 drug covered under Medicare Part D and will increase annually to 20 Part B and 20 Part D drugs by 2029 and thereafter, with the selected drugs accumulating from year to year. The same will be required under state Medicaid and CHIP programs by October 1, 2023.

article thumbnail

What RFK Jr. Isn’t Talking About: How To Make Vaccines Safer

Physician's Weekly

Within an hour of receiving a covid vaccination in November 2020, Utah preschool teacher Brianne Dressen felt pins and needles through her arms and legs. He directed the patients to seek local help. But for Dressen and others convinced the vaccines injured them, their experiences were symptomatic of a well-intentioned but flawed U.S.

article thumbnail

Drug Pricing Reform Gathers Steam (Part 2)

FDA Law Blog

This bill, which addresses numerous areas of the economy, public health, and government regulation, includes Subtitle E, Drug Pricing. Under all of these programs, patient co-insurance would be calculated based on the MFP so that patients receive the benefit of that price. The Part B rebate would exclude vaccines as well.